Patents by Inventor Soledad Valera

Soledad Valera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of screening for compounds that bind P2x receptor
    Patent number: 6194162
    Abstract: The P2X receptor of ATP has been cloned and expressed by recombinant DNA technology, so the receptor can be prepared free from other ATP receptors. The P2X receptor enables antibodies to be prepared and is useful in screening compounds for use in a variety of diseases and conditions, including epilepsy, cognition, emesis, pain (especially migraine), asthma, peripheral vascular disease, hypertension, diseases of the immune system, irritable bowel syndrome and premature ejaculation.
    Type: Grant
    Filed: July 30, 1999
    Date of Patent: February 27, 2001
    Assignee: Glaxo Group Limited
    Inventors: Soledad Valera, Gary N Buell
  • P.sub.2x receptor DNA and protein sequence
    Patent number: 5985603
    Abstract: The P.sub.2X receptor of ATP has been cloned and expressed by recombinant DNA technology, so the receptor can be prepared free from other ATP receptors. The P.sub.2X receptor enables antibodies to be prepared and is useful in screening compounds for use in a variety of diseases and conditions, including epilepsy, cognition, emesis, pain (especially migraine), asthma, peripheral vascular disease, hypertension, diseases of the immune system, irritable bowel syndrome and premature ejaculation.
    Type: Grant
    Filed: January 22, 1997
    Date of Patent: November 16, 1999
    Assignee: Glaxo Group Limited
    Inventors: Soledad Valera, Gary N Buell